Dmitry Kuzmin
Directeur/Membre du Conseil chez Araris Biotech AG
Provenance du réseau au premier degré de Dmitry Kuzmin
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University of Oxford
124
| College/University | Other Consumer Services | 124 |
Moscow State University Lomonosov
51
| College/University | Other Consumer Services | 51 |
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.
17
| Holding Company | Investment Managers | 17 |
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation.
9
| Holding Company | Biotechnology | 9 |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Araris Biotech AG
 Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Hornet Therapeutics Ltd.
 Hornet Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Hornet Therapeutics Ltd. is a British company founded in 2019 that provides immune cell metabolism and cell therapy for cancer treatment. The company is based in London, UK.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dmitry Kuzmin via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Chief Investment Officer | |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
HgCapital LLP
 HgCapital LLP Investment ManagersFinance HgCapital LLP (HgCapital) is a private equity firm founded in 1985 by Craig M. Donaldson. The firm is headquartered in London, United Kingdom with additional offices in Munich, Paris, New York and San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Chief Investment Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Corporate Officer/Principal | |
JPMorgan Securities Plc
 JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets. | Financial Conglomerates | Analyst-Equity Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree Graduate Degree | |
Brookson Management Services Ltd.
 Brookson Management Services Ltd. Financial ConglomeratesFinance Part of RCAF VI Mallard Holdings Ltd., Brookson Management Services Ltd. is a private investment group led by management of Rick and Carolyn Nevinson. The company is based in Warrington, UK. Brookson Management Services was founded in 2000. | Financial Conglomerates | Director/Board Member | |
| LaSalle University | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Director/Board Member Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Masters Business Admin | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| Villanova University | College/University | Masters Business Admin | |
| University College London | College/University | Undergraduate Degree Graduate Degree | |
| University of Zurich | College/University | Doctorate Degree Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Vitruvian Partners LLP
 Vitruvian Partners LLP Investment ManagersFinance Vitruvian Partners LLP (Vitruvian Partners) is a private equity firm founded in 2006 by Ian Riley, Michael Risman, Toby Wyles, Mark Harford and David Nahama. The firm is headquartered London, the United Kingdom with offices across the globe. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
| Licensing Executives Society | Corporate Officer/Principal | ||
| PUBLIC JOINT STOCK COMPANY TRANSCONTAINER | Railroads | Director/Board Member Director/Board Member | |
Genisphere LLC
 Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Max Planck Institute of Biochemistry | College/University | Doctorate Degree | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Enso Ventures Ltd.
 Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Private Equity Investor Director of Finance/CFO | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
| Lomonosov Moscow State University Business School | College/University | Doctorate Degree | |
| ARCELLX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Darwin Bidco Ltd.
 Darwin Bidco Ltd. MiscellaneousMiscellaneous Founded in 2016, Darwin Bidco Ltd. is a British company that functions as an investment holding company. Part of Riverside Partners LLC (New York), the company is based in London, UK. | Miscellaneous | Director/Board Member | |
UPMC Enterprises
 UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Consultant / Advisor | |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| 4bio Capital Partners | Investment Managers | Private Equity Investor | |
InTouch Accounting Ltd.
 InTouch Accounting Ltd. Miscellaneous Commercial ServicesCommercial Services InTouch Accounting Ltd. develops online accounting services. It offers taxation, company records information, freelancers, contractor accountants, and contractor tax specialists. The company was founded by Paul William Gough in 2010 and is headquartered in Bournemouth, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
jCyte, Inc.
 jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA. | Medical/Nursing Services | Chief Executive Officer Founder | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Director/Board Member | |
Darwin Topco Ltd. (Greater London)
 Darwin Topco Ltd. (Greater London) Packaged SoftwareTechnology Services Part of Riverside Partners LLC (New York), Darwin Topco Ltd. is a software development and British installation company that specializes in providing solutions for the hotel and hospitality industry. The company is based in London, UK. | Packaged Software | Director/Board Member | |
Darwin Holdco Ltd.
 Darwin Holdco Ltd. Financial ConglomeratesFinance Part of Riverside Partners LLC (New York), Darwin Holdco Ltd. is an investment holding British company. The company is based in London, UK. Darwin Holdco was founded in 2016. | Financial Conglomerates | Director/Board Member | |
Darwin Midco Ltd.
 Darwin Midco Ltd. Financial ConglomeratesFinance Founded in 2016, Darwin Midco Ltd. is a part of Riverside Partners LLC (New York) and functions as an investment holding British company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member | |
Brookson Construction Ltd.
 Brookson Construction Ltd. Miscellaneous Commercial ServicesCommercial Services Part of RCAF VI Mallard Holdings Ltd., Brookson Construction Ltd. is a contractor that offers specialist contractor accountancy, payroll, legal, and other services to support freelancers and self-employed workers throughout their career. Brookson Construction is based in Warrington, UK. The British company provides a cradle-to-grave solution for freelancers and self-employed workers, and also offers a compliance and workforce management platform for hirers. | Miscellaneous Commercial Services | Director/Board Member | |
| SG3 Ventures LLC | President | ||
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Hevolution Foundation | Corporate Officer/Principal | ||
MS WESTFALIA GmbH
 MS WESTFALIA GmbH Medical DistributorsDistribution Services MS Westfalia GmbH is a medical equipment company based in Troisdorf, Germany. MS Westfalia offers a range of medical equipment products, including anaesthesiology and ICU equipment, cleanrooms, X-ray machines, C-arms, physiotherapy and rehabilitation equipment, and more. The German company also provides training and technical support services for its equipment. MS Westfalia has won several awards for its innovative designs, including the Red Dot Award and the IF Design Award. The private company was founded in 1995, and the CEO is Eugen Kagan. | Medical Distributors | Private Equity Investor |
Statistiques
Internationale
| Etats-Unis | 23 |
| Royaume-Uni | 16 |
| Allemagne | 6 |
| Suisse | 5 |
| Russie | 3 |
Sectorielle
| Consumer Services | 16 |
| Finance | 15 |
| Health Technology | 8 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Opérationnelle
| Director/Board Member | 240 |
| Corporate Officer/Principal | 71 |
| Undergraduate Degree | 65 |
| Private Equity Investor | 48 |
| Independent Dir/Board Member | 41 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Anthony Evnin | 46 |
| Tiba Aynechi | 24 |
| Thomas Seddon | 18 |
| Gerald Joseph Rohan | 16 |
| Arnd Kaltofen-Ehmann | 16 |
| Brian McVeigh | 15 |
| Dominik Escher | 15 |
| Michael Sidler | 13 |
| Johan Krynauw | 12 |
| Victor Stone | 12 |
| Andrey Kozlov | 12 |
| Valery Pavlovich Goreglyad | 11 |
| Joseph Truitt | 10 |
| Kieran Mudryy | 10 |
- Bourse
- Insiders
- Dmitry Kuzmin
- Connexions Sociétés
